Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UNIPROT:P01178 (
oxytocin
)
15,767
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Bovine ovaries were obtained from the abattoir and corpora lutea were classified as: (1) early luteal phase (approximately Days 1-4); (2) mid-luteal phase (Days 5-10); (3) late luteal phase (Days 11-17); (4) regressing (Days 18-20) and (5) pregnant (Days 90-230). In addition, preovulatory follicles and whole ovaries without luteal tissue were collected. Concentrations of
oxytocin
, vasopressin, bovine
neurophysin I
and progesterone were measured in each corpus luteum by radioimmunoassay.
Progesterone
and
neurophysin I
levels increased from Stage 1 to Stage 2, plateaued during Stage 3 and declined by Stage 4.
Oxytocin
and vasopressin concentrations increased from Stage 1 to Stage 2 but declined during Stage 3 and were low (
oxytocin
) or undetectable (vasopressin) in follicles, whole ovaries and pregnancy corpora lutea. Therefore the concentrations of both peptide hormones were maximal during the first half of the cycle and declined before those of progesterone. The high concentration of
oxytocin
within the corpus luteum coupled with the presence of bovine
neurophysin I
suggests that
oxytocin
is synthesized locally.
...
PMID:Variations in oxytocin, vasopressin and neurophysin concentrations in the bovine ovary during the oestrous cycle and pregnancy. 674 62
Agents influencing the output of prostaglandin F2 alpha (PGF2 alpha) from non-pregnant endometrium were investigated by in vitro incubation, for 5 and 19h, using mid-cycle (day 7), end of cycle (day 15), or ovariectomised guinea-pigs. Estradiol 17-beta (10 micrograms/ml) stimulated PGF2 alpha output 24h after incubation with endometrium (p less than 0.05). This stimulation was greater at mid-cycle.
Progesterone
(50 ng/ml) inhibited output of PGF2 alpha (p less than 0.05) in mid-cycle, end of cycle and ovariectomised guinea-pig cultures.
Oxytocin
(1 X 10(-5) u/ml) stimulated the output of PGF2 alpha at the end of the cycle, but not at mid-cycle. However, in the presence of estradiol 17-beta (10 micrograms/ml),
oxytocin
stimulation of mid-cycle PGF2 alpha output was observed. The calcium ionophore A23187 (5 micrograms/ml) stimulated PGF2 alpha synthesis from mid-cycle and end-of-cycle endometrium, and this stimulation resembled that caused by arachidonic acid (100 micrograms/ml), suggesting an action via substrate mobilisation. Co-culture of endometrium and myometrium did not influence endometrial PGF2 alpha or myometrial 6-oxo-PGF2 output. It is suggested that the steroid hormones act as coarse modulators of endometrial PGF2 alpha output, but more rapid changes may be achieved by
oxytocin
and agents that mobilise substrate supply, possibly via calcium ion fluctuations.
...
PMID:Control of endometrial prostaglandin output in vitro during the estrous cycle of the guinea-pig: influence of estradiol 17-beta, progesterone, oxytocin and calcium ionophore A23187. 681 62
Progesterone
and unconjugated estriol are radioimmunologically estimated in 42 diabetic patients in amniotic fluid and serum during last weeks of pregnancy and in the course of
oxytocin
-induced parturition. As unconjugated estriol rises in progressing weeks of pregnancy progesterone remains unchanged in both investigated fluids. The quotient progesterone unconjugated estriol correlates with affection to labour. There is no statistically significant change in both steroid hormones during induced labour.
...
PMID:[Progesterone and unconjugated estriol in amniotic fluid and serum in diabetic patients during induction of labor]. 682 40
Fertilized eggs from rabbits 1 or 2.5 days after insemination were transferred to the oviduct or uterine horn of recipients that had received a single subcutaneous injection of 20 or 30 mg of one of seven long-acting progestins. The rabbits were observed daily, and the number of implantation sites was determined 10 or 11 days after egg transfer. No implantation sites were recorded in the recipient does treated with progesterone or ZK-5623 (Schering AG, Berlin, West Germany), a nor-steroid compound. Thirty-nine percent and 51% of the transferred eggs implanted in the recipient does treated with ZK-5410 (Schering AG) and chloromadinone acetate (Eli Lilly & Company, Indianapolis, IN), respectively. However, most of the pregnant animals aborted 14 to 20 days after egg transfer. The pregnancy was either maintained to term or was prolonged beyond the normal gestation length in the does treated with other compounds, ZK-53915, ZK-9349 (Schering AG) or
Depo-Provera
(Upjohn Company, Kalamazoo, MI). The young delivered after a subcutaneous injection of 17 beta-estradiol and
oxytocin
were found normal and active.
...
PMID:Maintenance of pregnancy in rabbits treated with long-lasting progestins. 685 82
Marked changes in the uterine binding of
oxytocin
(OT) occur in rats at the time of parturition or after treatment of ovariectomized rats with estrogen or progesterone. To ascertain that these binding sites represent the biological receptors for OT, we measured the uterine response to OT in various groups of rats in which specific OT binding was also determined. Intact pregnant rats and rats ovariectomized on day 20 of gestation and treated thereafter with oil, estradiol benzoate (5 micrograms/24 h), progesterone (5 mg/24 h), or estradiol and progesterone together had indwelling balloons inserted on day 20 for the recording of uterine response to either iv bolus injections or iv infusions of OT. The uterus was removed 24-48 h after balloon insertion, and OT binding to the particulate fraction as well as nuclear estrogen and cytosolic estrogen receptor concentrations were determined. An inverse correlation (r2 = 0.758) was found between the concentration of OT-binding sites and the threshold dose of OT, and a linear correlation was found between the concentration of binding sites and the uterine activity induced by OT infusion (r2 = 0.852). We conclude, therefore, that the high affinity (Kd, 1-2 nM) binding sites for OT represent the physiological receptors. The concentration of these sites increased progressively during estrogen treatment.
Progesterone
completely inhibited this estrogen-induced rise. After ovariectomy, there was a modest, but significant, increase in OT receptor concentration which also was prevented by progesterone. The increase in OT receptor concentration was correlated with the estrogen receptor concentration in intact pregnant and estrogen-treated ovariectomized animals, but not in the other groups of animals. The apparent affinity of the receptors for OT was not significantly affected by hormone treatment. We conclude that the concentration of receptors is a major factor controlling the uterine responsiveness to OT, and that the receptor concentrations are regulated by ovarian hormones in a manner related to estrogen receptor activation. In addition, estrogen appeared to enhance the coupling of OT receptor occupancy to the tissue response to OT.
...
PMID:Correlation between oxytocin receptor concentration and responsiveness to oxytocin in pregnant rat myometrium: effects of ovarian steroids. 687 47
On the 25th day of pregnancy, 14 New Zealand white rabbits were treated orally with 500 mg of the progesterone (P)-synthesis inhibitor: Isoxazol. This treatment was repeated 12 hours (n = 6) or 24 hours (n = 8) later. An additional group of 6 rabbits received at the same time the solvent, without Isoxazol, to serve as vehicle controls. From day 26 onward all these 20 animals were induced every day with a single i.v. injection of 100 mU
oxytocin
until they delivered. The 14 Isoxazol rabbits responded to
oxytocin
on day 27.7 plus or minus 0.2 (Mean plus or minus S.E.), while the vehicle controls failed to respond until day 30.3 plus or minus 0.4 of pregnancy (p smaller than 0.001).
Progesterone
assays in the uterine vein plasma showed that, in comparison with 14 untreated controls of similar gestational age, plasma P of the 14 Isoxazol rabbits was significantly reduced (p smaller than 0.01). The vehicle controls became inducable when their P was endogenously lowered to the level at which
oxytocin
readily provokes parturition near term. Neither Isoxazol, nor
oxytocin
altered the normally low prostaglandin F levels of the uterine vein plasma, indicating that Isoxazol provokes premature inducability in the rabbit through P-withdrawal, rather than through an elevation of PG-levels.
...
PMID:Induction of preterm labor in the rabbit by antiprogesterone. 746 53
It is well established that uterine
oxytocin
receptors (OTRs) are strongly up-regulated immediately before parturition as well as in response to estrogen (E2) administration.
Progesterone
(P4), on the other hand, induces a rapid down-regulation. We recently cloned the rat OTR gene and characterized its expression in the rat uterus. In this study, we examined the regulation of OTR messenger RNA (mRNA) levels in rat uterus during pregnancy, the estrous cycle, and in response to gonadal steroid treatment. OTR mRNA levels increased more than 25-fold during gestation: 4.5-fold during the first 21 days and 6-fold within 24 h between day 21 and the onset of parturition. Uterine OTR mRNA levels fell rapidly by 85% within 24 h following parturition. By in situ hybridization, OTR mRNA was localized specifically to the longitudinal and circular layers of the myometrium but was not detected in the endometrium. During the estrous cycle, OTR mRNA levels increased 2-fold between metestrus and proestrus, whereas
oxytocin
(OT) binding rose more than 10-fold within this same interval. Treatment of ovariectomized rats with E2 lead to a significant increase in both OTR mRNA levels (4.4-fold) and OT binding (< 6-fold). Cotreatment with P4 strongly reduced OT binding by 75% (P < 0.01) but did not significantly affect the E2-induced rise in OTR mRNA (11% decrease, P > 0.1). Our data suggest that the increased expression of OT binding sites observed at the onset of labor and at proestrus is mediated, at least in part, by an E2-induced up-regulation of OTR gene expression. However, it also appears that OTR mRNA levels are not the sole determinants of uterine OT binding. Specifically, P4-mediated OTR down-regulation cannot be explained by an effect on OTR mRNA accumulation and may involve novel mechanisms acting at translational or posttranslational levels.
...
PMID:Oxytocin receptor gene expression in the rat uterus during pregnancy and the estrous cycle and in response to gonadal steroid treatment. 758 81
It is not known whether the equine preovulatory follicle produces
oxytocin
or is a target tissue for
oxytocin
, as has been reported for other species, especially ruminants. Bovine granulosa cells secrete
oxytocin
, and
oxytocin
modulates the production of progesterone by granulosa cells in vitro. We examined whether
oxytocin
plays a comparable role in the equine preovulatory follicle. To test the hypothesis that the equine preovulatory follicle produces
oxytocin
during estrus and that its production increases in late estrus, preovulatory follicles were isolated during early (Days 1 to 2; n = 4) and late (Days 4 to 5; n = 4) estrus. Granulosa cells, pieces of theca interna and pieces of follicle wall (theca with attached granulosa cells) were cultured for 3 d with or without equine gonadotropins. Culture media were collected, replaced at 3, 6, 12, 24, 48, and 72 hr of culture, and assayed for
oxytocin
. Granulosa cells from preovulatory follicles secreted negligible amounts of
oxytocin
during 3 d of culture, irrespective of gonadotropin treatment or stage of estrus. Likewise, negligible amounts of
oxytocin
were measured in theca and follicle wall cultures at both developmental stages, in the presence or absence of gonadotropins. Furthermore, follicular fluid from early or late estrous follicles contained only negligible amounts of
oxytocin
. To determine if
oxytocin
affects steroidogenesis by equine granulosa cells, granulosa cells from follicles obtained on Day 2 of estrus were cultured with graded doses of
oxytocin
(0, 1, 10, 100, and 1,000 ng/ml) in defined medium supplemented with testosterone (0.5 microM) and culture media were assayed for estradiol-17 beta and progesterone. Estradiol was secreted throughout the culture period, and its production was not significantly affected by
oxytocin
treatment (P > 0.05).
Progesterone
secretion was relatively low during the first 24 hr of culture, increased dramatically on the second day of culture, and remained high through the third day. No dose of
oxytocin
had a significant effect on progesterone secretion (P > 0.05). In conclusion, the results indicate that equine preovulatory follicles, isolated during early or late estrus, are neither a source of
oxytocin
nor a target for
oxytocin
action on steroidogenesis. Although ovarian
oxytocin
appears to play a role in regulating follicular function in some other mammalian species, our data provide no support for such a role for
oxytocin
in mares.
...
PMID:Oxytocin in mares: lack of evidence for oxytocin production by or action on preovulatory follicles. 760 Jul 64
While the mechanism of the initiation of labor in humans has not been clarified satisfactorily, it is of major clinical interest, particularly with a view to understanding and avoiding preterm labor.
Progesterone
, whose role can now be determined in greater detail by the use of newly developed progesterone antagonists, and estrogens both play a role. Recently, attention has focused not only on contraction-stimulating substances such as
oxytocin
and prostaglandins, but also on cytokines, which have been implicated in the pathogenesis of preterm labor related to intrauterine infection. A model describing the various steps leading to regular uterine contractions is discussed and the resulting implications on stimulation and inhibition by pharmacological substances are outlined.
...
PMID:[Control of labor onset in the human]. 771 3
We have recently shown that
oxytocin
(OT) is synthesized within human amnion, chorion, and decidua during late gestation. The levels of OT messenger ribonucleic acid (mRNA) increased around the time of parturition, suggesting that locally produced OT may play a role in this poorly understood process. In this report, we present results from investigations into the effects of estrogen and progesterone on the synthesis of OT by human chorio-decidua. Using an in vitro incubation system, estradiol at physiological concentrations more than doubled the concentration of OT mRNA. This was reflected by an increase in the amount of OT peptide secreted into the medium. The increase in OT mRNA was antagonized by tamoxifen, suggesting that the effects were estrogen receptor mediated.
Progesterone
had no effect on OT mRNA synthesis. Using ribonuclease protection assays, mRNAs for estrogen receptor (ER) and progesterone receptor (PR) were detected in all tissues examined. The highest levels were found in decidua, with lower amounts in chorion and very small amounts in amnion and placenta. This is the same relative tissue distribution that we previously demonstrated for OT mRNA. A single transcript was present for ER, and two transcripts were protected for PR. The concentrations of ER mRNA in chorio-decidua were 3-fold higher in tissues obtained after spontaneous labor onset than in tissues obtained from cesarean section at a similar gestational age but before labor onset. Levels of PR did not change significantly. We conclude that synthesis of OT in human chorio-decidua may be regulated in part by estrogen, and that regulation of ER levels may be an important factor modulating this effect. These data support the hypothesis of a paracrine network within human fetal membranes and decidua that may participate in regulating the timing of human birth.
...
PMID:Estrogen stimulates oxytocin gene expression in human chorio-decidua. 785 22
<< Previous
1
2
3
4
5
6
7
8
9
10
Next >>